Management of hospitalized type 2 diabetes mellitus patients
| Autor: | Francisco Javier del Cañizo-Gómez, Juan José Marín-Peñalver, Iciar Martín-Timón |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Nephrology
medicine.medical_specialty endocrine system diseases type 2 diabetes mellitus medicine.medical_treatment nutritional support 030209 endocrinology & metabolism Review Article Hypoglycemia corticosteroids surgery 03 medical and health sciences 0302 clinical medicine Internal medicine Internal Medicine medicine In patient 030212 general & internal medicine Glycemic business.industry Insulin Type 2 Diabetes Mellitus nutritional and metabolic diseases medicine.disease in-hospital diabetes control Clinical trial Increased risk hypoglycemia hyperglycemia business incretins |
| Zdroj: | Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid Consejería de Sanidad de la Comunidad de Madrid |
| Popis: | Both hyperglycemia and hypoglycemia in hospitalized patients are associated with adverse outcomes including increased rates of infection, longer hospital length of stay, and even death. Clinical trials in patients with type 2 diabetes mellitus proved that by improving glycemic control, we can reduce all of them. Insulin is the preferred treatment for glycemic control in most cases, but alternative treatment options that can normalize blood glucose levels without hypoglycemia are being sought. Moreover, hospitalized patients are particularly vulnerable to severe, prolonged hypoglycemia since they may be unable to sense or respond to the early warning signs and symptoms of low blood glucose. Finally, nutritional support, corticosteroid therapy, and surgery increase the risk of hyperglycemia that leads to an increased risk of morbidity and mortality. We review the management of type 2 diabetes mellitus patients who are admitted to the general medical wards of the hospital for a procedure of intercurrent illness. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|